[1] 尉耘翠, 贾露露, 张萌, 等. 儿科医师对哮喘控制类用药——吸入性糖皮质激素的用药选择及对患者用药依从性评价的调查[J]. 中国药房, 2019, 30(3):408-412. [2] 张敏, 温志红, 杨彩琼. 达良好控制哮喘患儿停用低剂量吸入性糖皮质激素的临床随访研究[J]. 中国当代儿科杂志, 2019, 21(5):421-425. [3] 尉耘翠, 贾露露, 胡利华, 等. 儿童哮喘缓解期吸入性糖皮质激素用药依从性现况调查[J]. 中国医院药学杂志, 2019, 39(14):1494-1498. [4] 黄传君, 赵方正, 陈方方, 等. 吸入性糖皮质激素能有效控制支气管哮喘气道炎症[J]. 中华结核和呼吸杂志, 2018, 41(11):912. [5] 薛满, 喻钧. 不同联合药物雾化吸入方案对儿童支气管哮喘急性发作治疗效果及安全性的影响[J]. 中国妇幼保健, 2019, 34(3):550-553. [6] 中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南(2016年版)[J]. 中华儿科杂志, 2016, 54(3):167-181. [7] Maselli D J, Peters J I. Quadrupling inhaled glucocorticoid dose for deteriorating asthma control reduced severe exacerbations[J]. Annals of Internal Medicine, 2018, 168(12):65-66. [8] McKeever T, Mortimer K, Wilson A, et al. Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations[J]. The New England Journal of Medicine, 2018, 378(10):902-910. [9] Hashim Z, Neyaz Z, Kumar S, et al. Correlation of asthma severity, IgE level, and spirometry results with HRCT findings in allergic bronchopulmonary aspergillosis[J]. Indian Journal of Radiology and Imaging, 2020, 30(2):163-164. [10] Tanabe N, Sato S, Oguma T, et al. Influence of asthma onset on airway dimensions on ultra-high-resolution computed tomography in chronic obstructive pulmonary disease[J]. Journal of Thoracic Imaging, 2021, 36(4):224-230. [11] Silva T K B D, Zanon M, Altmayer S, et al. High-resolution CT pulmonary findings in children with severe asthma[J]. Jornal De Pediatria, 2021, 97(1):37-43. [12] Lin X F, Lin Y J, Lai Z D, et al. Retrospective comparison of high-resolution computed tomography of eosinophilic granulomatosis with polyangiitis with severe asthma[J]. Annals of Translational Medicine, 2021, 9(12):983-984. [13] Jung J W, Oh J S, Bae B, et al. Ultra-high-resolution computed tomography shows changes in the lungs related with airway hyperresponsiveness in a murine asthma model[J]. Scientific Reports, 2021, 11(1):17584-17585. [14] 徐盛威. HRCT在儿童支气管哮喘诊断中的应用[J]. 影像研究与医学应用, 2021, 5(5):218-219. [15] Hashimoto M, Tanaka H, Abe S. Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD[J]. Chest, 2005, 127(3):965-972. [16] Choi J Y, Yoon H K, Lee J H, et al. Nationwide use of inhaled corticosteroids by South Korean asthma patients:An examination of the Health Insurance Review and Service database[J]. Journal of Thoracic Disease, 2018, 10(9):5405-5413. [17] Awadh N, Müller N L, Park C S, et al. Airway wall thickness in patients with near fatal asthma and control groups:Assessment with high resolution computed tomographic scanning[J]. Thorax, 1998, 53(4):248-253. [18] Yang M J, Zhang Y, Chen H, et al. Inhaled corticosteroids and risk of upper respiratory tract infection in patients with asthma:A meta-analysis[J]. Infection, 2019, 47(3):377-385. [19] Choi Y J, Lee H Y, Yoon D, et al. Trabecular bone score is more sensitive to asthma severity and glucocorticoid treatment than bone mineral density in asthmatics[J]. Allergy, Asthma & Immunology Research, 2019, 11(3):343-356. |